Intranasal Administration of Bedaquiline-Loaded Fucosylated Liposomes Provides Anti-Tubercular Activity while Reducing the Potential for Systemic Side Effects

Authors: Franziska Marwitz (Bioanalytical Chemistry, Research Center Borstel, Leibniz Lung Center), Gabriela Hädrich (Department of Pharmaceutical Sciences, Faculty of Life Sciences, University of Vienna), Natalja Redinger (Cellular Microbiology, Research Center Borstel, Leibniz Lung Center), Karen F. W. Besecke (Rodos Biotarget GmbH), Feng Li (Department of Pharmaceutical Sciences, Faculty of Life Sciences, University of Vienna), Nadine Aboutara (Bioanalytical Chemistry, Research Center Borstel, Leibniz Lung Center), Simone Thomsen (Bioanalytical Chemistry, Research Center Borstel, Leibniz Lung Center), Michaela Cohrs (Institute of Pharmacy, Martin-Luther-Universität Halle-Wittenberg), Paul Robert Neumann (Institute of Pharmacy, Martin-Luther-Universität Halle-Wittenberg), Henrike Lucas (Institute of Pharmacy, Martin-Luther-Universität Halle-Wittenberg), Julia Kollan (Institute of Pharmacy, Martin-Luther-Universität Halle-Wittenberg), Constantin Hozsa (Rodos Biotarget GmbH), Robert K. Gieseler (Rodos Biotarget GmbH), Dominik Schwudke (Bioanalytical Chemistry, Research Center Borstel, Leibniz Lung Center), Marcus Furch (Rodos Biotarget GmbH), Ulrich Schaible (German Center for Infection Research, Thematic Translational Unit Tuberculosis), Lea Ann Dailey (Department of Pharmaceutical Sciences, Faculty of Life Sciences, University of Vienna)

Availability: http://data.europeana.eu/aggregation/europeana/1300/https___phaidra_univie_ac_at_o_2114568